Skip to main content

Advertisement

Contact Anke Reinacher-Schick

From: Effect of KRAS codon13 mutations in patients with advanced colorectal cancer (advanced CRC) under oxaliplatin containing chemotherapy. Results from a translational study of the AIO colorectal study group

Contact corresponding author